• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mcl-1在光敏化上皮来源与淋巴来源的人类癌细胞中的差异反应。

Differential responses of Mcl-1 in photosensitized epithelial vs lymphoid-derived human cancer cells.

作者信息

Xue Liang-yan, Chiu Song-mao, Oleinick Nancy L

机构信息

Department of Radiation Oncology and the Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106-4942, USA.

出版信息

Oncogene. 2005 Oct 20;24(46):6987-92. doi: 10.1038/sj.onc.1208837.

DOI:10.1038/sj.onc.1208837
PMID:16007152
Abstract

The antiapoptotic Bcl-2-family proteins, Bcl-2 and Bcl-xL, are recognized phototargets of photodynamic therapy (PDT) with the mitochondrion-targeting phthalocyanine photosensitizer Pc 4. In the present study, we found that myeloid cell leukemia 1 (Mcl-1), another antiapoptotic member of the Bcl-2 family, was not photodamaged in Pc 4-PDT-treated human carcinoma cells MCF-7c3, MDA-MB468, DU145, and A431, although Mcl-1 turnover was observed after exposure of HeLa or MCF-7c3 cells to a supralethal dose of UVC. In contrast, when human lymphoma U937 and Jurkat cells were treated with Pc 4-PDT, staurosporine (STS) or UVC, Mcl-1 was cleaved to generate a 28-kDa fragment over a 2-4 h period. The cleavage of Mcl-1 was accompanied by the activation of caspases-3, -9, and -8. The broad-specificity caspase inhibitor z-VAD-fmk completely blocked Mcl-1 cleavage induced by PDT, STS or UVC, providing evidence for Mcl-1 as a substrate for caspases. Western blot analysis localized Mcl-1 to mitochondria, ER, and cytosol of both MCF-7c3 and U937 cells, suggesting that Mcl-1 protein, unlike Bcl-2 and Bcl-xL, is not a target for Pc 4-PDT, probably due to its localization to sites removed from those of Pc 4 binding. The 28-kDa cleaved fragment of Mcl-1, which has proapoptotic activity, was produced in PDT-treated lymphoid-derived cells, but not in cells of epithelial origin, suggesting that PDT-induced rapid and extensive apoptosis in lymphoma cells may result in part from the sensitivity of their Mcl-1 to caspase cleavage, removing an important negative control on apoptosis.

摘要

抗凋亡的Bcl-2家族蛋白Bcl-2和Bcl-xL,是线粒体靶向酞菁光敏剂Pc 4光动力疗法(PDT)的公认光靶点。在本研究中,我们发现,Bcl-2家族的另一个抗凋亡成员髓样细胞白血病1(Mcl-1),在经Pc 4-PDT处理的人癌细胞MCF-7c3、MDA-MB468、DU145和A431中未受到光损伤,尽管在HeLa或MCF-7c3细胞暴露于超致死剂量的紫外线C(UVC)后观察到了Mcl-1的周转。相反,当用人淋巴瘤U937和Jurkat细胞进行Pc 4-PDT、星形孢菌素(STS)或UVC处理时,Mcl-1在2至4小时内被切割产生一个28 kDa的片段。Mcl-1的切割伴随着半胱天冬酶-3、-9和-8的激活。广谱特异性半胱天冬酶抑制剂z-VAD-fmk完全阻断了由PDT、STS或UVC诱导的Mcl-1切割,为Mcl-1作为半胱天冬酶的底物提供了证据。蛋白质印迹分析将Mcl-1定位于MCF-7c3和U937细胞的线粒体、内质网和细胞质中,这表明Mcl-1蛋白与Bcl-2和Bcl-xL不同,不是Pc 4-PDT的靶点,可能是由于其定位于远离Pc 4结合位点的位置。具有促凋亡活性的Mcl-1的28 kDa切割片段在经PDT处理的淋巴来源细胞中产生,但在上皮来源细胞中未产生,这表明PDT诱导淋巴瘤细胞快速广泛凋亡可能部分是由于其Mcl-1对半胱天冬酶切割敏感,从而消除了对凋亡的重要负调控。

相似文献

1
Differential responses of Mcl-1 in photosensitized epithelial vs lymphoid-derived human cancer cells.Mcl-1在光敏化上皮来源与淋巴来源的人类癌细胞中的差异反应。
Oncogene. 2005 Oct 20;24(46):6987-92. doi: 10.1038/sj.onc.1208837.
2
Photodamage to multiple Bcl-xL isoforms by photodynamic therapy with the phthalocyanine photosensitizer Pc 4.使用酞菁光敏剂Pc 4通过光动力疗法对多种Bcl-xL亚型进行光损伤。
Oncogene. 2003 Dec 18;22(58):9197-204. doi: 10.1038/sj.onc.1207019.
3
Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4.与Jurkat T细胞相较于A431表皮样细胞对酞菁Pc 4光动力疗法敏感性增加相关的凋亡机制
Photochem Photobiol. 2008 Mar-Apr;84(2):407-14. doi: 10.1111/j.1751-1097.2007.00278.x. Epub 2008 Jan 23.
4
Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage.基于Bcl-2光损伤的癌症光动力治疗定制方法。
Int J Oncol. 2008 Oct;33(4):689-96.
5
Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4.使用酞菁光敏剂Pc 4进行光动力治疗期间Bcl - 2癌蛋白的光化学破坏。
Oncogene. 2001 Jun 7;20(26):3420-7. doi: 10.1038/sj.onc.1204441.
6
The death of human cancer cells following photodynamic therapy: apoptosis competence is necessary for Bcl-2 protection but not for induction of autophagy.光动力疗法后人类癌细胞的死亡:凋亡能力对于Bcl-2保护是必要的,但对于自噬诱导并非必要。
Photochem Photobiol. 2007 Sep-Oct;83(5):1016-23. doi: 10.1111/j.1751-1097.2007.00159.x.
7
Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s10 (Na).溶酶体组织蛋白酶引发细胞凋亡,在使用新型光敏剂ATX-s10(钠)的光动力疗法中,细胞凋亡受线粒体中Bcl-2的光损伤调节。
Int J Oncol. 2006 Aug;29(2):349-55.
8
Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.抗氧化剂和半胱天冬酶-3抑制剂对苯乙基异硫氰酸酯诱导的人PLC/PRF/5细胞凋亡信号通路的影响。
Eur J Pharmacol. 2005 Aug 22;518(2-3):96-106. doi: 10.1016/j.ejphar.2005.06.021.
9
A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.Mcl-1在硼替佐米诱导的细胞凋亡中起关键作用。
Oncogene. 2008 Jan 31;27(6):721-31. doi: 10.1038/sj.onc.1210679. Epub 2007 Jul 23.
10
Killing efficacy of a new silicon phthalocyanine in human melanoma cells treated with photodynamic therapy by early activation of mitochondrion-mediated apoptosis.一种新型硅酞菁通过早期激活线粒体介导的凋亡对接受光动力疗法治疗的人黑色素瘤细胞的杀伤效果
Exp Dermatol. 2004 Jan;13(1):33-44. doi: 10.1111/j.0906-6705.2004.00147.x.

引用本文的文献

1
Target Prediction of 5,10,15,20-Tetrakis(4'-Sulfonatophenyl)-Porphyrin Using Molecular Docking.基于分子对接的5,10,15,20-四(4'-磺酸基苯基)卟啉的靶点预测
Pharmaceutics. 2022 Nov 5;14(11):2390. doi: 10.3390/pharmaceutics14112390.
2
Serine 162, an essential residue for the mitochondrial localization, stability and anti-apoptotic function of Mcl-1.丝氨酸 162 是 Mcl-1 在线粒体定位、稳定和抗凋亡功能中必需的残基。
PLoS One. 2012;7(9):e45088. doi: 10.1371/journal.pone.0045088. Epub 2012 Sep 14.
3
Promotion of PDT efficacy by a Bcl-2 antagonist.
一种Bcl-2拮抗剂对光动力疗法疗效的促进作用。
Photochem Photobiol. 2008 May-Jun;84(3):809-14. doi: 10.1111/j.1751-1097.2007.00267.x. Epub 2007 Dec 20.
4
Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies.使用酞菁光敏剂Pc 4进行光动力疗法:临床前机制研究和早期临床转化研究的病例经验
Toxicol Appl Pharmacol. 2007 Nov 1;224(3):290-9. doi: 10.1016/j.taap.2007.01.025. Epub 2007 Feb 15.
5
Ceramide response post-photodamage is absent after treatment with HA14-1.使用HA14-1治疗后,光损伤后的神经酰胺反应消失。
Biochem Biophys Res Commun. 2006 Jun 30;345(2):803-8. doi: 10.1016/j.bbrc.2006.04.131. Epub 2006 May 2.